D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$3.68B |
| 2 |
Boeing
BA
|
+$959M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$875M |
| 4 |
Tesla
TSLA
|
+$835M |
| 5 |
Eli Lilly
LLY
|
+$643M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$939M |
| 2 |
Palantir
PLTR
|
+$668M |
| 3 |
Apple
AAPL
|
+$644M |
| 4 |
Workday
WDAY
|
+$525M |
| 5 |
Spotify
SPOT
|
+$451M |
Sector Composition
| 1 | Technology | 20.55% |
| 2 | Consumer Discretionary | 13.27% |
| 3 | Healthcare | 12.29% |
| 4 | Financials | 8.39% |
| 5 | Industrials | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2601
4D Molecular Therapeutics
FDMT
$324M
| $201K | ﹤0.01% |
36,033
-3,117
| -8% | -$17.4K |
|
2602
Transcat
TRNS
$705M
| $200K | ﹤0.01% |
1,895
| – | – |
|
2603
Open Lending Corp
LPRO
$253M
| $200K | ﹤0.01% |
33,483
-18,279
| -35% | -$109K |
|
|
IMTXW
2604
DELISTED
Immatics N.V. Warrants
IMTXW
| $199K | ﹤0.01% |
792,353
+462,330
| +140% | +$116K |
|
2605
Douglas Emmett
DEI
$2.75B
| $198K | ﹤0.01% |
10,662
-13,192
| -55% | -$245K |
|
2606
SES AI Corporation Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
SES.WS
$51.1M
| $198K | ﹤0.01% |
988,099
| – | – |
|
|
SAFE
2607
Safehold
SAFE
$1.15B
| $194K | ﹤0.01% |
+10,510
| New | +$194K |
|
|
OCSAW
2608
Oculis Holding AG Warrants
OCSAW
$346M
| $192K | ﹤0.01% |
35,616
-1,600
| -4% | -$8.62K |
|
2609
Keros Therapeutics
KROS
$636M
| $192K | ﹤0.01% |
12,099
-174,189
| -94% | -$2.76M |
|
2610
Petco
WOOF
$1B
| $190K | ﹤0.01% |
49,948
-1,441,287
| -97% | -$5.49M |
|
2611
908 Devices
MASS
$206M
| $189K | ﹤0.01% |
85,860
+28,263
| +49% | +$62.2K |
|
2612
1-800-Flowers.com
FLWS
$326M
| $186K | ﹤0.01% |
22,804
-6,087
| -21% | -$49.7K |
|
2613
Expro
XPRO
$1.42B
| $183K | ﹤0.01% |
+14,696
| New | +$183K |
|
2614
Broadstone Net Lease
BNL
$3.52B
| $183K | ﹤0.01% |
+11,537
| New | +$183K |
|
2615
UWM Holdings
UWMC
$1.49B
| $180K | ﹤0.01% |
30,726
-349,450
| -92% | -$2.05M |
|
2616
Magnachip Semiconductor
MX
$110M
| $177K | ﹤0.01% |
44,105
+29,023
| +192% | +$117K |
|
|
CTV
2617
DELISTED
Innovid Corp.
CTV
| $177K | ﹤0.01% |
+57,279
| New | +$177K |
|
2618
Immatics
IMTX
$706M
| $176K | ﹤0.01% |
24,734
-38,913
| -61% | -$277K |
|
2619
ARKO Corp
ARKO
$563M
| $175K | ﹤0.01% |
+26,547
| New | +$175K |
|
2620
iHeartMedia
IHRT
$323M
| $172K | ﹤0.01% |
+86,772
| New | +$172K |
|
|
UNIT
2621
Uniti Group
UNIT
$1.69B
| $169K | ﹤0.01% |
+30,720
| New | +$169K |
|
2622
Fossil Group
FOSL
$159M
| $165K | ﹤0.01% |
98,530
-308,703
| -76% | -$516K |
|
2623
Nektar Therapeutics
NKTR
$916M
| $163K | ﹤0.01% |
11,680
+8,498
| +267% | +$119K |
|
2624
Arcos Dorados Holdings
ARCO
$1.47B
| $162K | ﹤0.01% |
22,253
+12,217
| +122% | +$88.9K |
|
|
HPAI
2625
Helport AI Limited Ordinary Shares
HPAI
$146M
| $162K | ﹤0.01% |
29,152
| – | – |
|